Insider Transactions in Q4 2023 at Bio Rad Laboratories, Inc. (BIO)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2023
|
Dara Wright EVP, President, CDG |
SELL
Payment of exercise price or tax liability
|
Direct |
174
-8.7%
|
$53,244
$306.12 P/Share
|
|
Dec 16
2023
|
Dara Wright EVP, President, CDG |
BUY
Exercise of conversion of derivative security
|
Direct |
502
+20.06%
|
-
|
|
Dec 12
2023
|
Dara Wright EVP, President, CDG |
SELL
Open market or private sale
|
Direct |
1,200
-44.46%
|
$358,800
$299.16 P/Share
|
|
Dec 05
2023
|
Steven D Schwartz > 10% Shareholder |
BUY
Bona fide gift
|
Indirect |
49
+0.38%
|
-
|
|
Dec 05
2023
|
Steven D Schwartz > 10% Shareholder |
BUY
Bona fide gift
|
Direct |
49
+0.19%
|
-
|
|
Dec 05
2023
|
Schwartz Allison Director |
BUY
Bona fide gift
|
Direct |
49
+1.23%
|
-
|
|
Dec 05
2023
|
Norman D Schwartz Chairman & CEO |
BUY
Bona fide gift
|
Indirect |
49
+0.38%
|
-
|
|
Dec 05
2023
|
Norman D Schwartz Chairman & CEO |
BUY
Bona fide gift
|
Direct |
49
+0.01%
|
-
|
|
Dec 05
2023
|
Alice N Schwartz > 10% Shareholder |
SELL
Bona fide gift
|
Indirect |
294
-0.07%
|
-
|
|
Dec 05
2023
|
Alice N Schwartz > 10% Shareholder |
SELL
Bona fide gift
|
Indirect |
3,270
-0.18%
|
-
|
|
Nov 28
2023
|
Michael Crowley EVP, GBL Commercial Operations |
SELL
Open market or private sale
|
Direct |
642
-8.47%
|
$195,810
$305.1 P/Share
|
|
Nov 01
2023
|
Norman D Schwartz Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
49,940
-4.42%
|
$13,633,620
$273.0 P/Share
|
|
Nov 01
2023
|
Norman D Schwartz Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
66,000
+5.48%
|
$9,174,000
$139.56 P/Share
|